May 29 (Reuters) - Aroa Biosurgery Ltd ARX.AX:
FY PRODUCT REVENUE NZD 84 MILLION
FY ADJUSTED EBITDA NZD 4.2 MILLION
FY PRODUCT GROSS MARGIN 86%
FY ADJUSTED EBIT NZD -800 THOUSAND
FY GROSS PROFIT NZD 72.6 MILLION
FY ADJUSTED OPERATING EXPENSES NZD 74.5 MILLION
TOTAL REVENUE GUIDANCE OF NZ$92-100 MILLION FOR FY26
SEES FY NORMALISED EBITDA OF NZ$5-8 MILLION
Further company coverage: ARX.AX
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.